 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...

Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference

This indicator may be signaling STTK's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Shattuck Labs (STTK, $8.96) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

This indicator may be signaling that STTK's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Shattuck Labs (STTK, $8.96) entered Downtrend as Momentum indicator drops below 0 level on Mar 27, 2024

Shattuck Labs (STTK, $9.47) entered Uptrend as Momentum indicator ascends above 0 level on Mar 20, 2024

Shattuck Labs (STTK, $8.71) entered Downtrend as Momentum indicator drops below 0 level on Mar 15, 2024

Shattuck Labs, Inc. (NASDAQ:STTK  Get Free Report) insider Stephen Stout sold 16,004 shares of the stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of...

Shattuck Labs, Inc. (NASDAQ:STTK) Insider Sells $168,522.12 in Stock

Shattuck Labs (STTK, $9.13) entered Downtrend as Momentum indicator drops below 0 level on Mar 08, 2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Shattuck Labs appoints Siegall, Sasser to board of directors

AUSTIN, TX and DURHAM, NC, March 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion...

Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors

HC Wainwright reaffirmed their buy rating on shares of Shattuck Labs (NASDAQ:STTK  Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has...

HC Wainwright Reaffirms Buy Rating for Shattuck Labs (NASDAQ:STTK)

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Volume (M)	88,895.00
52-Wk High	$11.11
52-Wk Low	$1.33

STTK Shattuck Labs Inc

About

Feed

News

Sentiment

Earnings

Fundamentals